Search in:

Current Medical Research and Opinion Volume 36, 2020 - Issue 8

Submit an article Journal homepage

Open access

3,424

Views

CrossRef citations to date

Altmetric

Gastroenterology

Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population

Dominic PilonAnalysis Group, Inc, Montreal, Canada; Correspondence[email protected]

Zhijie DingReal World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA

Erik MuserReal World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA

Camilo ObandoReal World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA

Jennifer VoelkerReal World Value and Evidence, Janssen Scientific Affairs, LLC, Horsham, PA, USA

Ameur M. ManceurAnalysis Group, Inc, Montreal, Canada;

Frederic KinkeadAnalysis Group, Inc, Montreal, Canada;

Marie-Hélène LafeuilleAnalysis Group, Inc, Montreal, Canada;

Patrick LefebvreAnalysis Group, Inc, Montreal, Canada;

show all

Pages 1285-1294 | Received 13 Mar 2020, Accepted 08 May 2020, Published online: 09 Jun 2020

Cite this article
https://doi.org/10.1080/03007995.2020.1771293
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (13)

Maryia Zhdanava, Ruizhi Zhao, Ameur M. Manceur, Zhijie Ding, Julien Boudreau, Sumesh Kachroo, Caroline Kerner, James Izanec & Dominic Pilon. (2024) Economic and clinical burden of chronic corticosteroid use in patients with Crohn[apos]s disease initiated on biologic or conventional therapies in the US: A retrospective claims study. Journal of the American Pharmacists Association 64:2, pages 386-394.e10.
Crossref

Maryia ZhdanavaRuizhi ZhaoAmeur M. ManceurZhijie DingJulien BoudreauSumesh KachrooCaroline KernerJames IzanecDominic Pilon. (2024) Burden of chronic corticosteroid use among patients with ulcerative colitis initiated on targeted treatment or conventional therapy in the United States. Journal of Managed Care & Specialty Pharmacy 30:2, pages 141-152.
Crossref

Bincy P. Abraham, Christopher Fan, Theresa Thurston, Joshua Moskow & Hoda M. Malaty. (2023) The Role of Vitamin D in Patients with Inflammatory Bowel Disease Treated with Vedolizumab. Nutrients 15:22, pages 4847.
Crossref

Bruce E Sands, Brian G Feagan, Theresa Hunter Gibble, Kristina A Traxler, Nathan Morris, William J Eastman, Stefan Schreiber, Vipul Jairath, Millie D Long & Alessandro Armuzzi. (2023) Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies. Crohn's & Colitis 360 5:4.
Crossref

David Singer, Philippe Thompson-Leduc, Deepshekhar Gupta, Sara Poston, Wendy Y Cheng, Siyu Ma, John E Pawlowski, Mei Sheng Duh, Francesca Devine, Azeem Banatwala, Emma Bernstein & Francis A Farraye. (2023) Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States. Crohn's & Colitis 360 5:3.
Crossref

Allie Cichewicz, Tom Tencer, Komal Gupte-Singh, Sonya Egodage, Heather Burnett & Jinender Kumar. (2023) A Systematic Review of the Economic and Health-Related Quality of Life Impact of Advanced Therapies Used to Treat Moderate-to-Severe Ulcerative Colitis. Advances in Therapy 40:5, pages 2116-2146.
Crossref

Zhijie Ding, Erik Muser, James Izanec, Rina Lukanova, James Kershaw & Adam Roughley. (2022) Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn’s Disease or Ulcerative Colitis in the United States. Crohn's & Colitis 360 4:3.
Crossref

Christine A. Simon, Eloise Salmon, Hailey E. Desmond, Susan F. Massengill, Wilson P. Gipson & Debbie S. Gipson. (2022) The Health Economic Impact of Nephrotic Syndrome in the United States. Kidney360 3:6, pages 1073-1079.
Crossref

Jan Sieluk, Yan Song, Jonathan Freimark, Min Huang, Amin Haiderali, Richard Berman, Travis Wang, James Signorovitch & Kim Marie Hirshfield. (2021) The Economic Burden of Recurrence in Triple-Negative Breast Cancer Among Working Age Patients in the United States. Advances in Therapy 39:2, pages 943-958.
Crossref

Jesse Ortendahl, Sabyasachi Ghosh, Ninfa Candela, Tao Fan & Kandavadivu Umashankar. (2021) S768 Costs for Treating Patients With Ulcerative Colitis With Vedolizumab or Adalimumab Based on Endoscopic Improvement Data From the VARSITY Trial. American Journal of Gastroenterology 116:1, pages S355-S355.
Crossref

Manish Mittal, Min Yang, Manan Shah, Wei Gao, Christopher Carley & Bruce W. Sherman. (2021) Impact of Medication Adherence on Healthcare Resource Utilization, Work Loss, and Associated Costs in a Privately Insured Employed Population Treated With Adalimumab in the United States. Journal of Occupational & Environmental Medicine 63:10, pages e724-e731.
Crossref

Reinier Cornelis Anthonius van Linschoten, Elyke Visser, Christa Diana Niehot, C. Janneke van der Woude, Jan Antonius Hazelzet, Desirée van Noord & Rachel Louise West. (2021) Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents. Alimentary Pharmacology & Therapeutics 54:3, pages 234-248.
Crossref

Celine Miyazaki, Nagano Katsumasa, Kuan Chih Huang & Yan Fang Liu. (2021) Evaluation of economic burden with biologic treatments in Crohn’s disease patients: A mirror image study using an insurance database in Japan. PLOS ONE 16:7, pages e0254807.
Crossref

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population

Articles from other publishers (13)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population

Citations (13)

Articles from other publishers (13)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date